ORPHELIA Pharma
Manufacturing · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
85 Boulevard, Paris, Ile-de-France, 7500...Phone Number
+33 142770818Website
www.orphelia-pharma.euRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About ORPHELIA Pharma
ORPHELIA Pharma is a biopharmaceutical company based in Paris and Lyon that develops and markets drugs for the treatment of pediatric and orphan diseases. ORPHELIA's mission is to provide patients with essential hospital products in the fields of epilepsy and oncology, with formulations that are suited to the pediatric population. With 2 products approved in the European Union and one project in late-stage clinical development, ORPHELIA Pharma recently sets up regional agreements in the EU, the USA and China and conducts research projects through academic and industrial partnerships.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ORPHELIA Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ORPHELIA Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ORPHELIA Pharma
ORPHELIA Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ORPHELIA Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ORPHELIA Pharma has new funding data
Check out if ORPHELIA Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if ORPHELIA Pharma had a recent Job posting/layoffs
Check if ORPHELIA Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at ORPHELIA Pharma
Find 2 more new buyers
Company Profile Activity
Activity Insights
ORPHELIA Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ORPHELIA Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ORPHELIA Pharma.
ORPHELIA Pharma Tech Stack
A closer look at the technologies used by ORPHELIA Pharma
See more technologies
ORPHELIA Pharma News & Media
ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program for KIMOZO® (temozolomide) in European Countries
PARIS & CHARLOTTE, N.C.--(BUSINESS WIRE)--ORPHELIA Pharma and Tanner Pharma Group have signed an exclusive agreement to manage the supply and distribution of Ped-TMZ, also known as KIMOZO®.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ORPHELIA Pharma
Sign Up For FreeTo access detailed company insights
ORPHELIA Pharma is a biopharmaceutical company based in Paris and Lyon that develops and markets drugs for the treatment of pediatric and orphan diseases. ORPHELIA's mission is to provide patients with essential hospital products in the fields of epilepsy and oncology, with formulations that are suited to the pediatric population. With 2 products a... Read More
